Recurrent Central Nervous System Tumors

  • Melvin Deutsch
Part of the Foundations of Neurological Surgery book series (FONS, volume 3)


As with most other childhood malignancies, the reappearance of an intracranial tumor either locally or at distant sites after primary therapy implies a dire prognosis. However, retreatment may provide long subsequent survival or even cure of patients with recurrent biologically non-aggressive tumors such as pituitary adenoma, craniopharyngioma, meningioma, and cerebellar astrocytoma. Even the patient with a recurrent biologically aggressive tumor such as medulloblastoma may derive significant palliation and even cure from retreatment. Retreatment is more likely to be beneficial if administered when the recurrent tumor is still localized to a small volume and before apparent dissemination via the cerebral spinal fluid (CSF) pathways has occurred. Also, retreatment will be better tolerated if administered before deterioration in neurological status.


Pituitary Adenoma Posterior Fossa Cerebral Spinal Fluid Central Nervous System Tumor Childhood Brain Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Marton LJ, Edwards MS, Levin VA, Lubich WP, Wilson CB: CSF polyamines: A new and important means of monitoring patients with medulloblastoma. Cancer 47:757–760, 1981.PubMedCrossRefGoogle Scholar
  2. 2.
    Phillips PC, Kremzner LT, De Vivo DC: Cerebrospinal fluid polyamines: Biochemical markers of malignant childhood brain tumors. Ann Neurol 19:360–364, 1986.PubMedCrossRefGoogle Scholar
  3. 3.
    Berry MP, Jenkin RDT, Keen CW, Nair BD, Simpson WJ: Radiation treatment for medulloblastoma. A 21 year review. J Neurosurg 55: 43–51, 1981.PubMedCrossRefGoogle Scholar
  4. 4.
    Brand WN, Schneider PA, Tokars RP: Long-term results of a pilot study of low dose cranial-spinal irradiation for cerebellar medulloblastoma. Int J Radiat Oncol Biol Phys 13: 1641–1645, 1987.PubMedCrossRefGoogle Scholar
  5. 5.
    Silverman CL, Simpson JR: Cerebellar medulloblastoma: The importance of posterior fossa dose to survival and patterns of failure. Int J Radiat Oncol Biol Phys 8:1869–1876, 1982.PubMedCrossRefGoogle Scholar
  6. 6.
    Harisiadis L, Chang CH: Medulloblastoma in children: A correlation between staging and results of treatment. Int J Radiol Oncol Biol Phys 2:833–841, 1977.CrossRefGoogle Scholar
  7. 7.
    McFarland DR, Horwitz H, Saenger EL, Bahr GK: Medulloblastoma. A review of prognosis and survival. Br J Radiol 42:198–214, 1969.PubMedCrossRefGoogle Scholar
  8. 8.
    Deutsch M: Medulloblastoma; Staging and treatment outcome. Int J Radiat Oncol Biol Phys 14:1103–1107, 1988.PubMedCrossRefGoogle Scholar
  9. 9.
    Duffner PK, Cohen ME: Extraneural metastases in childhood brain tumors. Ann Neurol 10: 261–265, 1981.PubMedCrossRefGoogle Scholar
  10. 10.
    Herz DA, Shapiro K, Shulman K: Intracranial meningiomas of infancy, childhood and adolescence. Review of the literature and addition of 9 case reports. Childs Brain 7:43–56, 1980.PubMedGoogle Scholar
  11. 11.
    Leibel SA, Wara WM, Sheline GE, Townsend JJ, Boldrey EB: The treatment of meningiomas in childhood. Cancer 37:2709–2712, 1976.PubMedCrossRefGoogle Scholar
  12. 12.
    Chan RC, Thompson GB: Intracranial meningiomas in childhood. Surg Neurol 21:319–322, 1984.PubMedCrossRefGoogle Scholar
  13. 13.
    Gutin PH, Phillips TL, Wara WM, Leibel SA, Hosobuchi Y, Levin VA, Weaver KA, Lamb S: Brachytherapy of recurrent malignant brain tumors with removable high-activity iodine-125 sources. J Neurosurg 60:61–68, 1984.PubMedCrossRefGoogle Scholar
  14. 14.
    Allen JC, Bloom J, Ertel I, Evans A, Hammond D, Jones H, Levin V, Jenkin D, Sposto R, Wara W: Brain tumors in children: Current cooperation and institutional chemotherapy trials in newly diagnosed and recurrent disease. Semin Oncol 13:110–122, 1986.PubMedGoogle Scholar
  15. 15.
    Bleyer W, Millstein J, Balais F, Pendergrass T, Chard R, Hartman J: 8 drugs in 1 day chemotherapy for brain tumors: A new approach and rationale for preradiation chemotherapy. Med Pediatr Oncol 11:213 (abstract), 1983.Google Scholar
  16. 16.
    Bloom HJG: Intracranial tumors: Response and resistance to therapeutic endeavors, 1970–1980. Int J Radiat Oncol Biol Phys 8:1083–1113, 1982.PubMedGoogle Scholar
  17. 17.
    Kida Y, Kobayashi T, Yoshida J, Kato K, Kageyama N: Chemotherapy with cisplatin for AFP secreting germ cell tumors of the central nervous system. J Neurosurg 65:470–475, 1986.PubMedCrossRefGoogle Scholar
  18. 18.
    Matsutani M, Takakura K, Sano K: Primary intracranial germ cell tumors: Pathology and treatment. Prog Exp Tumor Res 30:307–312, 1987.PubMedGoogle Scholar
  19. 19.
    Allen JC, Kim JH, Packer RJ: Neoadjuvant chemotherapy for newly diagnosed germ-cell tumors of the central nervous system. J Neurosurg 67:65–70, 1987.PubMedCrossRefGoogle Scholar
  20. 20.
    Allen JC, Nisselbaum J, Epstein F, Rosen G, Schwartz MK: Alphafetoprotein and human chorionic gonadotropin determination in cerebrospinal fluid. An aid to the diagnosis and management of intracranial germ cell tumors. J Neurosurg 51:368–374, 1979.PubMedCrossRefGoogle Scholar
  21. 21.
    Neuwelt EA, Frenkel EP, Smith RG: Suprasellar germinomas (ectopic pinealomas): Aspects of immunological characterization and successful chemotherapeutic responses in recurrent disease. Neurosurgery 7:352–358, 1980.PubMedCrossRefGoogle Scholar
  22. 22.
    Siegel T, Pfeffer MR, Catane R, Sulkes A, Gomori MJ, Fuks Z: Successful chemotherapy of recurrent intracranial germinoma with spinal metastases. Neurology 33:631–633, 1983.Google Scholar
  23. 23.
    Rosen G, Ghavimi F, Nirenberg A, Mosende C, Mehta BM: High dose methotrexate with citrovorum factor rescue for the treatment of CNS tumours in children. Cancer Treat Rep 61: 681–690, 1977.PubMedGoogle Scholar
  24. 24.
    Mooney C, Souhami R, Pritchard J: Recurrent medulloblastoma. Lack of response to high-dose methotrexate. Cancer Chemother Pharmacol 10:135–136, 1983.PubMedCrossRefGoogle Scholar
  25. 25.
    Allen JC, Helson L: High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. J Neurosurg 55:749–756, 1981.PubMedCrossRefGoogle Scholar
  26. 26.
    Cangir A, van Eys J, Berry DH, Hvizdala E, Morgan SK: Combination chemotherapy with MOPP in children with recurrent brain tumors. Med Pediatr Oncol 4:253–261, 1978.PubMedCrossRefGoogle Scholar
  27. 27.
    Hochberg FH, Parker LM, Takvorian T, Canellos GP, Zervas NT: High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme. J Neurosurg 54: 455–460, 1981.PubMedCrossRefGoogle Scholar
  28. 28.
    Zeltzer PM: Chemotherapy for medulloblastoma: A review of treatment in recurrent and de novo tumors. In Zeltzer PM, Pochedly C (eds), Medulloblastoma in Children. New Concepts in Tumor Biology, Diagnosis and Treatment. New York: Praeger, 1986, pp 182–199.Google Scholar
  29. 29.
    Allen JC: Systemic metastases from medulloblastoma: Response to chemotherapy. In Zeltzer PM, Pochedly C (eds), New Concepts in Tumor Biology, Diagnosis and Treatment. New York: Praeger, 1986, pp 200–212.Google Scholar
  30. 30.
    Wilson ER, Takei Y, Bikoff WT, O’Brien MS, Tindall GT, Boehm WM: Abdominal metastases of primary intracranial yolk sac tumors through ventriculoperitoneal shunts: Report of three cases. Neurosurgery 5:356–364, 1979.PubMedCrossRefGoogle Scholar
  31. 31.
    Gay JC, Janco RL, Lukens JN: Systemic metastases in primary intracranial germinoma. Cancer 55:2688–2690, 1985.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1990

Authors and Affiliations

  • Melvin Deutsch

There are no affiliations available

Personalised recommendations